You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Mallinckrodt
AstraZeneca
Harvard Business School
Merck

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 9,717,763

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,717,763
Title:Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
Abstract: Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.
Inventor(s): Mistry; Sanjay (Downingtown, PA), Kihm; Anthony J. (Princeton, NJ), Harris; Ian R. (Radnor, PA), Harmon; Alexander M. (Clifton, NJ), Messina; Darin J. (Downingtown, PA), Seyda; Agnieszka (Edison, NJ), Yi; Chin-Feng (Hillsborough, NJ), Gosiewska; Anna (Skillman, NJ)
Assignee: DEPUY SYNTHES PRODUCTS, INC. (Raynham, MA)
Application Number:14/018,842
Patent Claims:see list of patent claims

Details for Patent 9,717,763

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bausch And Lomb VITRASE hyaluronidase INJECTABLE;INJECTION 021640 001 2004-12-21   Start Trial DEPUY SYNTHES PRODUCTS, INC. (Raynham, MA) 2023-06-27 RX search
Bausch And Lomb VITRASE hyaluronidase INJECTABLE;INJECTION 021640 002 2004-12-21   Start Trial DEPUY SYNTHES PRODUCTS, INC. (Raynham, MA) 2023-06-27 RX search
Amphastar Pharm AMPHADASE hyaluronidase INJECTABLE;INJECTION 021665 001 2005-11-03   Start Trial DEPUY SYNTHES PRODUCTS, INC. (Raynham, MA) 2023-06-27 RX search
Akorn Inc HYDASE hyaluronidase INJECTABLE;INJECTION 021716 001 2005-10-25   Start Trial DEPUY SYNTHES PRODUCTS, INC. (Raynham, MA) 2023-06-27 DISCN search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Boehringer Ingelheim
Medtronic
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.